Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Soluble immunologic products in scleroderma sera.

¹Department of Medicine, Medical University of South Carolina, Charleston 29425.

Clinical Immunology and Immunopathology

|January 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vascular involvement in systemic sclerosis (SSc).

Clinical and experimental rheumatology·2004

Same author

Regulation of substance P mRNA expression in human dermal microvascular endothelial cells.

Clinical and experimental rheumatology·2004

Same author

Beauty and the beast. The nitric oxide paradox in systemic sclerosis.

Rheumatology (Oxford, England)·2002

Same author

Reproducible gene expression measurement among multiple laboratories obtained in a blinded study using standardized RT (StaRT)-PCR.

Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology·2002

Same author

Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome.

Chest·2001

Same author

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

Autoimmunity·2000

Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020

Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998

Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998

Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998

Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998

Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998

See all related articles

This study reveals immune system activation in scleroderma (SSc) patients, with elevated levels of certain cytokines and immune markers like soluble interleukin-2 receptor and CD8. These findings suggest a role for these mediators in SSc pathogenesis.

Area of Science:

Immunology
Rheumatology
Biochemistry

Background:

Scleroderma (systemic sclerosis, SSc) is a complex autoimmune disease characterized by fibrosis.
The precise immune mechanisms underlying SSc pathogenesis remain incompletely understood.

Purpose of the Study:

To investigate the role of immune mechanisms in scleroderma by measuring specific cytokines and soluble immune markers in patient sera.
To identify potential biomarkers associated with disease activity and immune cell involvement in SSc.

Main Methods:

Serum samples were collected from 42 SSc patients and 14 healthy controls.
Levels of tumor necrosis factor (TNF), lymphotoxin, Interleukin-1 beta (IL-1 beta), Interleukin-2 (IL-2), soluble IL-2 receptor, soluble CD4, and CD8 were quantified.
Statistical analysis was performed to compare marker levels between SSc patients and controls.

Related Experiment Videos

Main Results:

Elevated levels of IL-2 receptor and CD8 were observed in SSc patients compared to controls (p<0.001 and p<0.05, respectively).
TNF, lymphotoxin, IL-1 beta, and IL-2 were detected in SSc patients but not in controls.
Soluble CD4 was also detected in a subset of SSc patients.

Conclusions:

The findings suggest ongoing immune cell activation, particularly involving the CD4+ subset, in SSc.
Elevated levels of TNF, IL-1 beta, and lymphotoxin indicate their potential involvement in the disease process.
These immune markers may serve as potential therapeutic targets or diagnostic indicators for SSc.